Stock AnalizHealthpeak Properties (DOC) earnings for the quarter ended September 2026: EPS beats estimates
Healthpeak Properties reported results for the quarter ended September 2026 on November 2, 2026. Adjusted earnings per share came in at $0.04 against the analysts’ average forecast of $0.03, a beat of 54.4%.
Revenue for the quarter was $814 million, up 15.3% from $706 million in the same quarter a year earlier.
The market’s verdict: the stock rose 2.8% on the first trading day after the report.
The last four quarters
Healthpeak Properties has beaten the analysts’ EPS forecast in 4 of the last 4 quarters.
| Quarter | EPS | Forecast | Surprise | Revenue growth | Price reaction |
|---|---|---|---|---|---|
| Sep 2026 | $0.04 | $0.03 | +54.4% | +15% | +2.8% |
| Jun 2026 | $0.08 | $0.03 | +198.6% | +11% | +0.7% |
| Mar 2026 | $0.28 | $0.06 | +364.7% | +7% | +19.7% |
| Dec 2025 | $0.10 | $0.06 | +59.3% | +3% | −4.6% |
What comes next
Analysts expect EPS of $0.03 for the next quarter on average and $0.09 for the fiscal year ending December 31, 2026.
The average analyst price target is $22.50, 13% above the current price of $19.98.
Valuation and score
Healthpeak Properties scores 1.8 out of 5 overall on Stock Analiz (weak), trades at a trailing P/E of about 37.0, and its intrinsic value under moderate assumptions is about 31% above the current market value. Full Healthpeak Properties analysis with 10 years of financials
Frequently asked questions
What was Healthpeak Properties’s EPS for the quarter ended September 2026?
$0.04 adjusted per share, against an analyst consensus of $0.03.
How much revenue did Healthpeak Properties report?
$814 million, up 15.3% year over year.
More
This report was written automatically from the published numbers within hours of the release. It is information, not investment advice.